Elderly And Younger Patients With Non-Small Cell Lung Cancer (Nsclc) Derive Similar Benefit From Second-Line Chemotherapy: A Retrospective Subset Analysis Of Second-Line Chemotherapy Trials Conducted From The Hellenic Cooperative Research Group (Horg).